G20's Challenges Highlight the Erosion of International Solidarity
- French President Macron warns G20 may face "end of a cycle" due to geopolitical fractures and U.S. multilateralism retreat. - G20 summit in Africa appears weakened by Trump's absence, China's nonattendance, and sparse leadership participation. - Trump's 28-point Ukraine peace plan sparks controversy, criticized as favoring Russia while demanding territorial concessions. - Macron highlights global governance dysfunction, stressing inability to uphold sovereignty and humanitarian law in conflicts. - Summit
French President Emmanuel Macron, recognized for his candid critiques of international organizations, has once again raised concerns—this time suggesting that the Group of 20 (G20) could be approaching the "close of an era" as geopolitical divisions deepen and the U.S. moves away from multilateral engagement. Speaking at the G20 summit in Johannesburg on November 22, Macron highlighted the fragile state of global cooperation, with the group struggling to reconcile diverging interests and
This G20 summit, the first ever held on African soil, was already undermined by Trump's decision not to attend—a move the U.S. administration justified by citing conflicting priorities with South Africa. The absence of the U.S., along with China and other key figures such as Italy's Giorgia Meloni, led Macron to describe the gathering as "lukewarm." He pointed to the "uninspiring visuals" of the group photo, where the sparse turnout and lack of iconic scenery reflected
Macron, who previously labeled NATO as "brain dead," portrayed the G20's difficulties as part of a wider global malaise. "We are finding it hard to establish a unified approach to geopolitical crises," he remarked, referencing the failure to uphold humanitarian principles and sovereignty in conflicts such as Ukraine. His concerns mirror growing worries about the weakening of multilateralism, especially as both the U.S. and China turn inward. South African President Cyril Ramaphosa, who hosted the summit, attempted to dispel the gloom, asserting that
The summit's final statement, which urged a "just" resolution for Ukraine and other disputes, was approved despite resistance from Argentina's Foreign Minister Pablo Quirno regarding the treatment of the Israel-Palestine conflict. European diplomats admitted that Trump's plan needs further refinement but emphasized that any deal must have the backing of both NATO and the EU. At the same time,
As the G20 confronts an unpredictable path forward, Macron's comments capture a widespread unease about the decline of collective action in an increasingly divided world. His dual critiques—of NATO and the G20—underscore his reputation as a challenger of institutional inertia, even as his own presidency approaches its 2027 conclusion. Ultimately,
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats
- ECB warns U.S. equity/crypto corrections threaten stability, urging central banks to retain rate-cut flexibility amid market volatility. - JPMorgan links crypto ETF outflows to retail investor behavior, noting $4B November sales contrast with $96B equity ETF inflows. - U.S. Treasury downplays recession risks, citing 2026 growth optimism despite shutdown impacts and services-driven inflation. - MSCI highlights tech valuation risks akin to dot-com era, while DeFi faces $12B liquidity crisis with 95% capita

Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats
- Novartis raised 2030 sales growth targets to 5-6% annually, driven by high peak sales expectations for oncology drugs Kisqali and Scemblix. - CEO Vas Narasimhan highlighted eight de-risked drugs with $3-10B peak potential, but analysts warned of patent expirations and uncertain pipeline progress beyond 2030. - Shares rose 0.5% post-announcement, while Exact Sciences surged 17% on its $105/share acquisition by Abbott and Samsung Biologics saw a 71% valuation re-rating after spin-off. - J.P. Morgan caution

Institutional Blockchain Integration: Blockdaemon and 21shares Bridge Traditional Finance and Web3 through the Canton Network
- Blockdaemon's Institutional Vault now supports Canton Coin, enabling secure custody and tokenization for institutions on the Canton Network. - 21shares launched a Canton Coin ETP on Euronext, offering investors institutional-grade exposure to privacy-focused blockchain innovation. - Canton Network's architecture, backed by J.P. Morgan and Goldman Sachs , facilitates secure, interoperable transactions while maintaining regulatory compliance. - Partnerships between blockchain infrastructure providers and t

LINK Price Moves to $13.90 as Market Tracks Tight Short-Term Structure
